Compiègne, France
Compiègne, France

Time filter

Source Type

Passariello A.,University of Naples Federico II | Agricole P.,Biocodex | Malfertheiner P.,Otto Von Guericke University of Magdeburg
Current Medical Research and Opinion | Year: 2014

Probiotics may be registered as food supplements or drugs. This article summarizes differences in European regulations of probiotics registered as food supplements and drugs, as well as issues related to the quality of probiotic products. For registration as a drug, the European Medicines Agency demands extensive and detailed quality, efficacy and safety evidence; whereas compulsory analyses requested for food supplements consist only in a nutritional analysis. As a result, the quality of those probiotics registered as drugs, compared to food supplements, is in general controlled with higher standards. Despite these differences and whatever the status of the probiotic product, its efficacy and safety has to be documented in well conducted randomized controlled trials (RCTs). Furthermore, this paper reviews recent evidence on the use of probiotics for gastrointestinal diseases, evaluating all the existing information up to January 2014. In all eligible published studies in which use of probiotics for gastrointestinal diseases were investigated and reported, no language limitations were applied. Special focus is placed on RCTs (or their meta-Analyses) showing positive results, so that the findings may be applicable to everyday clinical practice. Currently, the best documented clinical areas appear to be probiotics efficacy for the treatment of acute gastroenteritis in children and for the prevention of antibiotic-Associated diarrhea both in children and in adults. In other gastrointestinal conditions, some promising observations are emerging, but no definitive conclusions can be reached at present. © 2014 2014 Informa UK Ltd.


The present invention relates to a compound of the following formula (I):for use in the prevention or treatment of attention deficit and/or hyperactivity in an individual.


The present invention relates to a compound of the following formula (I):for use in the prevention or treatment of obsessions and/or compulsions in an individual.


The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of attention deficit and/or hyperactivity in an individual.


Patent
Biocodex | Date: 2014-11-07

The present invention relates to a pharmaceutical composition comprising, as active substance, Saccharomyces boulardii yeast cells, for use for reducing body fat in an individual.


The present invention relates to a compound of the following formula (I):


The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.


The present invention relates to a compound of the following formula (I):for use in the prevention or treatment of autism spectrum disorders (ASD).


Pharmaceutical preparations for the treatment of intestinal and vaginal diseases; pharmaceutical preparations, namely, probiotics made from yeast extract; food supplements for medical purposes; nutritional supplements for medical purposes; dietetic foods and dietetic beverages, namely, dietary meal replacement bars, gels and powdered drink mixes for medical use; foods supplements for use as part of a normal diet. Engineering services in the field of evaluations, assessments and research, in technological fields, provided by engineers; compiling data for research purposes in the field of medical science featuring analysis and editing of information and results obtained in surveys, work and opinion polls in the field of scientific and medical research; research and development of new products for others; technical projects studies, namely, conducting scientific feasibility studies; clinical trials for others in the medical field; medical research services; research services in the field of health; analysis and research services in the field of chemistry; conducting scientific feasibility studies; quality evaluation of medicines and other food supplements for medical purposes.


Trademark
Biocodex | Date: 2016-10-04

Dietetic substances, namely, dietary supplements for medical use containing Saccharomyces boulardii yeast for use in enhancing the normal functioning of the gastrointestinal tract and to aid in restoring normal colonic microflora in humans; pharmaceutical products for the prevention and treatment of gastroenterological disorders; dietary food supplements for human beings.

Loading Biocodex collaborators
Loading Biocodex collaborators